Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.

Thompson T, Poulter D, Miles C, Solmi M, Veronese N, Carvalho AF, Stubbs B, Uc EY.

Neurology. 2018 Sep 4;91(10):e906-e916. doi: 10.1212/WNL.0000000000006132. Epub 2018 Aug 3. Review.

PMID:
30076275
2.

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tröster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D.

NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018. Review.

3.

Longitudinal decline of driving safety in Parkinson disease.

Uc EY, Rizzo M, O'Shea AMJ, Anderson SW, Dawson JD.

Neurology. 2017 Nov 7;89(19):1951-1958. doi: 10.1212/WNL.0000000000004629. Epub 2017 Oct 11.

4.

Separating the effect of reward from corrective feedback during learning in patients with Parkinson's disease.

Freedberg M, Schacherer J, Chen KH, Uc EY, Narayanan NS, Hazeltine E.

Cogn Affect Behav Neurosci. 2017 Jun;17(3):678-695. doi: 10.3758/s13415-017-0505-0.

PMID:
28397140
5.

Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease.

Valdés EG, O'Connor ML, Uc EY, Hauser RA, Andel R, Edwards JD.

Int J Neurosci. 2017 Oct;127(10):841-848. doi: 10.1080/00207454.2016.1269088. Epub 2016 Dec 20.

PMID:
27919204
6.

Establishing an evidence-base framework for driving rehabilitation in Parkinson's disease: A systematic review of on-road driving studies.

Devos H, Ranchet M, Emmanuel Akinwuntan A, Uc EY.

NeuroRehabilitation. 2015;37(1):35-52. doi: 10.3233/NRE-151239. Review.

PMID:
26409692
7.

Gestures make memories, but what kind? Patients with impaired procedural memory display disruptions in gesture production and comprehension.

Klooster NB, Cook SW, Uc EY, Duff MC.

Front Hum Neurosci. 2015 Jan 13;8:1054. doi: 10.3389/fnhum.2014.01054. eCollection 2014.

8.

Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

Uc EY, Doerschug KC, Magnotta V, Dawson JD, Thomsen TR, Kline JN, Rizzo M, Newman SR, Mehta S, Grabowski TJ, Bruss J, Blanchette DR, Anderson SW, Voss MW, Kramer AF, Darling WG.

Neurology. 2014 Jul 29;83(5):413-25. doi: 10.1212/WNL.0000000000000644. Epub 2014 Jul 2.

9.

Cognitive impairment and dementia in Parkinson's disease: practical issues and management.

Emre M, Ford PJ, Bilgiç B, Uç EY.

Mov Disord. 2014 Apr 15;29(5):663-72. doi: 10.1002/mds.25870. Review.

PMID:
24757114
10.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
11.

On-road driving impairments in Huntington disease.

Devos H, Nieuwboer A, Vandenberghe W, Tant M, De Weerdt W, Uc EY.

Neurology. 2014 Mar 18;82(11):956-62. doi: 10.1212/WNL.0000000000000220. Epub 2014 Feb 12.

PMID:
24523484
12.

Driving and off-road impairments underlying failure on road testing in Parkinson's disease.

Devos H, Vandenberghe W, Tant M, Akinwuntan AE, De Weerdt W, Nieuwboer A, Uc EY.

Mov Disord. 2013 Dec;28(14):1949-56. doi: 10.1002/mds.25701. Epub 2013 Oct 24.

PMID:
24166984
13.

Impact of specific executive functions on driving performance in people with Parkinson's disease.

Ranchet M, Paire-Ficout L, Uc EY, Bonnard A, Sornette D, Broussolle E.

Mov Disord. 2013 Dec;28(14):1941-8. doi: 10.1002/mds.25660. Epub 2013 Oct 1.

PMID:
24114952
14.

Randomized trial of cognitive speed of processing training in Parkinson disease.

Edwards JD, Hauser RA, O'Connor ML, Valdés EG, Zesiewicz TA, Uc EY.

Neurology. 2013 Oct 8;81(15):1284-90. doi: 10.1212/WNL.0b013e3182a823ba. Epub 2013 Sep 6.

15.

Naturalistic distraction and driving safety in older drivers.

Aksan N, Dawson JD, Emerson JL, Yu L, Uc EY, Anderson SW, Rizzo M.

Hum Factors. 2013 Aug;55(4):841-53.

16.

Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.

Narayanan NS, Rodnitzky RL, Uc EY.

Rev Neurosci. 2013;24(3):267-78. doi: 10.1515/revneuro-2013-0004. Review.

17.

Validation of a screening battery to predict driving fitness in people with Parkinson's disease.

Devos H, Vandenberghe W, Nieuwboer A, Tant M, De Weerdt W, Dawson JD, Uc EY.

Mov Disord. 2013 May;28(5):671-4. doi: 10.1002/mds.25387. Epub 2013 Feb 23.

PMID:
23436270
18.

Parkinson disease and driving: an evidence-based review.

Crizzle AM, Classen S, Uc EY.

Neurology. 2012 Nov 13;79(20):2067-74. doi: 10.1212/WNL.0b013e3182749e95. Review.

19.

Neuropsychological assessment of driving safety risk in older adults with and without neurologic disease.

Anderson SW, Aksan N, Dawson JD, Uc EY, Johnson AM, Rizzo M.

J Clin Exp Neuropsychol. 2012;34(9):895-905. doi: 10.1080/13803395.2011.630654. Epub 2012 Sep 3.

20.

Clinical predictors of driving status in Huntington's disease.

Beglinger LJ, Prest L, Mills JA, Paulsen JS, Smith MM, Gonzalez-Alegre P, Rowe KC, Nopoulos P, Uc EY.

Mov Disord. 2012 Aug;27(9):1146-52. doi: 10.1002/mds.25101. Epub 2012 Jun 28.

21.

Predictors of driving outcomes in advancing age.

Emerson JL, Johnson AM, Dawson JD, Uc EY, Anderson SW, Rizzo M.

Psychol Aging. 2012 Sep;27(3):550-9. doi: 10.1037/a0026359. Epub 2011 Dec 19.

22.

Body mass index in Parkinson's disease: a meta-analysis.

van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR, Overeem S, Munneke M.

Parkinsonism Relat Disord. 2012 Mar;18(3):263-7. doi: 10.1016/j.parkreldis.2011.10.016. Epub 2011 Nov 18.

PMID:
22100523
23.

Cognitive functioning predicts driver safety on road tests 1 and 2 years later.

Aksan N, Anderson SW, Dawson JD, Johnson AM, Uc EY, Rizzo M.

J Am Geriatr Soc. 2012 Jan;60(1):99-105. doi: 10.1111/j.1532-5415.2011.03739.x. Epub 2011 Oct 31.

24.

Real-life driving outcomes in Parkinson disease.

Uc EY, Rizzo M, Johnson AM, Emerson JL, Liu D, Mills ED, Anderson SW, Dawson JD.

Neurology. 2011 May 31;76(22):1894-902. doi: 10.1212/WNL.0b013e31821d74fa.

25.

A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group.

Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362.

26.

Neuropsychological predictors of driving errors in older adults.

Dawson JD, Uc EY, Anderson SW, Johnson AM, Rizzo M.

J Am Geriatr Soc. 2010 Jun;58(6):1090-6. doi: 10.1111/j.1532-5415.2010.02872.x. Epub 2010 May 7.

27.

Prediction of driving ability with neuropsychological tests: demographic adjustments diminish accuracy.

Barrash J, Stillman A, Anderson SW, Uc EY, Dawson JD, Rizzo M.

J Int Neuropsychol Soc. 2010 Jul;16(4):679-86. doi: 10.1017/S1355617710000470. Epub 2010 May 5.

28.

Detection of imminent collisions by drivers with Alzheimer's disease and Parkinson's disease: a preliminary study.

Vaux LM, Ni R, Rizzo M, Uc EY, Andersen GJ.

Accid Anal Prev. 2010 May;42(3):852-8. doi: 10.1016/j.aap.2009.07.009.

29.

Driving difficulties in Parkinson's disease.

Rizzo M, Uc EY, Dawson J, Anderson S, Rodnitzky R.

Mov Disord. 2010;25 Suppl 1:S136-40. doi: 10.1002/mds.22791.

30.

Road safety in drivers with Parkinson disease.

Uc EY, Rizzo M, Johnson AM, Dastrup E, Anderson SW, Dawson JD.

Neurology. 2009 Dec 15;73(24):2112-9. doi: 10.1212/WNL.0b013e3181c67b77. Erratum in: Neurology. 2010 Mar 9;74(10):865.

31.

ASCERTAINMENT OF ON-ROAD SAFETY ERRORS BASED ON VIDEO REVIEW.

Dawson JD, Uc EY, Anderson SW, Dastrup E, Johnson AM, Rizzo M.

Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des. 2009 Dec 1;2009:419-426.

32.

COLLISION AVOIDANCE TRAINING USING A DRIVING SIMULATOR IN DRIVERS WITH PARKINSON'S DISEASE: A PILOT STUDY.

Dawson JD, Rizzo M, Anderson SW, Dastrup E, Uc EY.

Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des. 2009 Dec 1;2009:154-160.

33.

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC; Parkinson Study Group DATATOP Investigators.

Neurology. 2009 Nov 3;73(18):1469-77. doi: 10.1212/WNL.0b013e3181bf992f.

34.

Driving under low-contrast visibility conditions in Parkinson disease.

Uc EY, Rizzo M, Anderson SW, Dastrup E, Sparks JD, Dawson JD.

Neurology. 2009 Oct 6;73(14):1103-10. doi: 10.1212/WNL.0b013e3181bacf6e. Erratum in: Neurology. 2010 Feb 16;74(7):616.

35.

Predictors of driving safety in early Alzheimer disease.

Dawson JD, Anderson SW, Uc EY, Dastrup E, Rizzo M.

Neurology. 2009 Feb 10;72(6):521-7. doi: 10.1212/01.wnl.0000341931.35870.49.

36.

Impaired Curve Negotiation in Drivers with Parkinson's Disease.

Uc EY, Rizzo M, Dastrup E, Sparks J, Anderson SW, Rodnitzky RL, Dawson JD.

Turk Noroloji Dergisi. 2009 Jan 19;15(1):10-18. No abstract available.

37.

Driving and neurodegenerative diseases.

Uc EY, Rizzo M.

Curr Neurol Neurosci Rep. 2008 Sep;8(5):377-83. Review.

38.

Impaired navigation in drivers with Parkinson's disease.

Uc EY, Rizzo M, Anderson SW, Sparks JD, Rodnitzky RL, Dawson JD.

Brain. 2007 Sep;130(Pt 9):2433-40. Epub 2007 Aug 8.

PMID:
17686809
39.

Deep brain stimulation in movement disorders.

Uc EY, Follett KA.

Semin Neurol. 2007 Apr;27(2):170-82. Review.

PMID:
17390262
40.

Driving with distraction in Parkinson disease.

Uc EY, Rizzo M, Anderson SW, Sparks JD, Rodnitzky RL, Dawson JD.

Neurology. 2006 Nov 28;67(10):1774-80.

PMID:
17130409
41.

Unsafe rear-end collision avoidance in Alzheimer's disease.

Uc EY, Rizzo M, Anderson SW, Shi Q, Dawson JD.

J Neurol Sci. 2006 Dec 21;251(1-2):35-43. Epub 2006 Oct 16.

PMID:
17049360
42.

Impaired visual search in drivers with Parkinson's disease.

Uc EY, Rizzo M, Anderson SW, Sparks J, Rodnitzky RL, Dawson JD.

Ann Neurol. 2006 Oct;60(4):407-13.

PMID:
16969860
43.

Predictors of weight loss in Parkinson's disease.

Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ.

Mov Disord. 2006 Jul;21(7):930-6.

PMID:
16534756
44.

Visual dysfunction in Parkinson disease without dementia.

Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD.

Neurology. 2005 Dec 27;65(12):1907-13. Epub 2005 Nov 9.

PMID:
16282276
45.

Driver landmark and traffic sign identification in early Alzheimer's disease.

Uc EY, Rizzo M, Anderson SW, Shi Q, Dawson JD.

J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):764-8.

46.

Driver route-following and safety errors in early Alzheimer disease.

Uc EY, Rizzo M, Anderson SW, Shi Q, Dawson JD.

Neurology. 2004 Sep 14;63(5):832-7.

PMID:
15365132
47.

Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson disease.

Uc EY, Lambert CP, Harik SI, Rodnitzky RL, Evans WJ.

Clin Neuropharmacol. 2003 Jul-Aug;26(4):207-12.

PMID:
12897642
48.

The midlatency auditory evoked potential P50 is abnormal in Huntington's disease.

Uc EY, Skinner RD, Rodnitzky RL, Garcia-Rill E.

J Neurol Sci. 2003 Aug 15;212(1-2):1-5.

PMID:
12809992
49.

Juvenile parkinsonism.

Uc EY, Rodnitzky RL.

Semin Pediatr Neurol. 2003 Mar;10(1):62-7. Review.

PMID:
12785749
50.

Childhood dystonia.

Uc EY, Rodnitzky RL.

Semin Pediatr Neurol. 2003 Mar;10(1):52-61. Review.

PMID:
12785748

Supplemental Content

Support Center